DEF 14C

INFORMATION STATEMENT

Company: Sunshine Biopharma Inc.
Filed: January 31, 2019
Period of Report: February 1, 2019
Accession Number: 0001654954-19-000911

View Document ↗ View on SEC.gov ↗